That question presupposes doubt, but I see no reason for that doubt based on what we know. In this industry, extended due diligence and negotiation periods are the norm. Can you clarify exactly what details you have that would cause you to question the company's approach?
- Forums
- ASX - By Stock
- PAR
- Where are we on a deal?
PAR
paradigm biopharmaceuticals limited..
Add to My Watchlist
4.48%
!
32.0¢

Where are we on a deal?, page-1177
Featured News
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
|
|||||
Last
32.0¢ |
Change
-0.015(4.48%) |
Mkt cap ! $124.6M |
Open | High | Low | Value | Volume |
33.5¢ | 34.0¢ | 31.5¢ | $215.7K | 663.5K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
3 | 30081 | 31.5¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
32.5¢ | 10905 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
3 | 30081 | 0.315 |
4 | 40360 | 0.310 |
2 | 71752 | 0.305 |
2 | 52500 | 0.300 |
4 | 117881 | 0.295 |
Price($) | Vol. | No. |
---|---|---|
0.325 | 10905 | 1 |
0.330 | 10 | 1 |
0.335 | 3500 | 1 |
0.340 | 113110 | 3 |
0.350 | 53621 | 7 |
Last trade - 16.10pm 27/06/2025 (20 minute delay) ? |
Featured News
PAR (ASX) Chart |
The Watchlist
PAR
PARADIGM BIOPHARMACEUTICALS LIMITED..
Paul Rennie, MD & Founder
Paul Rennie
MD & Founder
SPONSORED BY The Market Online